spesicor 100 mg tabletti
schering oy - metoprololi tartras - tabletti - 100 mg - metoprololi
trasicor retard 80 mg depottabletti
novartis pharma stein ag - oxprenololi hydrochloridum - depottabletti - 80 mg - oksprenololi
trasicor retard 160 mg depottabletti
ciba-geigy - oxprenololi hydrochloridum - depottabletti - 160 mg - oksprenololi
spesicor 25 mg tabletti
oy leiras finland ab - metoprololi tartras - tabletti - 25 mg - metoprololi
spesicor 200 mg depottabletti
schering oy - metoprololi tartras - depottabletti - 200 mg - metoprololi
spesicor 100 mg depottabletti
schering oy - metoprololi tartras - depottabletti - 100 mg - metoprololi
posicor 50 mg tabletti
roche registration limited - mibefradili dihydrochloridum - tabletti - 50 mg - mibefradiili
posicor 100 mg tabletti
roche registration limited - mibefradili dihydrochloridum - tabletti - 100 mg - mibefradiili
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - budesonidi / formoterol teva pharma b. on tarkoitettu aikuisille vain 18-vuotiaille ja vanhemmille. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.
airexar spiromax
teva b.v. - salmeterol fluticasone propionate - pulmonary disease, chronic obstructive; asthma - obstruktiivisten hengitystiesairauksien lääkkeet, - airexar spiromax on tarkoitettu käytettäväksi vain 18-vuotiailla ja sitä vanhemmilla aikuisilla. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. krooninen obstruktiivinen keuhkosairaus (copd)airexar spiromax on tarkoitettu oireenmukaiseen hoitoon potilailla, joilla on copd, fev1.